Emerging Viruses 2026: H5N1, Mpox & Oropouche – What to Watch For
- As we enter February 14, 2026, the landscape of viral threats continues to evolve, keeping infectious disease specialists on high alert.
- Several viruses are drawing particular attention from experts this year.
- Perhaps the least known of the three, the Oropouche virus is transmitted by small mosquitoes and causes symptoms similar to the flu.
As we enter , the landscape of viral threats continues to evolve, keeping infectious disease specialists on high alert. A combination of factors – global warming, population growth, and increased human mobility – is creating increasingly favorable conditions for viruses to mutate and spread rapidly.
Several viruses are drawing particular attention from experts this year. These include influenza A, specifically the avian flu strain H5N1, mpox, and the Oropouche virus. While distinct from one another, these viruses share a concerning trend: they are expanding their geographic reach and demonstrating the potential for further transmission.
Oropouche Virus: An Emerging Threat Expanding from the Amazon
Perhaps the least known of the three, the Oropouche virus is transmitted by small mosquitoes and causes symptoms similar to the flu. First identified in Trinidad in the 1950s, it was long considered limited to the Amazon region. However, since the 2000s, it has been spreading throughout South America, Central America, and the Caribbean.
In 2024, deaths associated with the virus were documented for the first time in Brazil, and cases linked to travelers were reported in Europe, according to IFL Science. Cases of vertical transmission – from mother to child – have also been detected, and a possible link to cases of microcephaly is under investigation.
This is particularly concerning because the transmitting insect has adapted to wide areas of the continent and is also present in southeastern regions of the United States. Currently, there are no specific vaccines or treatments available.
In response, the World Health Organization (WHO) published a roadmap on , to accelerate the development of prevention and control tools against Oropouche.
Influenza A (H5N1): From Poultry to Humans
Influenza A has historically been a constant threat due to its rapid mutation rate and ability to infect various species. The 2009 H1N1 pandemic caused over 280,000 deaths worldwide in its first year.
Currently, attention is focused on H5N1, or avian flu. This virus moved beyond being solely a concern for birds in 2024, when it was first detected in dairy cows in the United States. This jump to a new species raised concerns among experts, as the detection wasn’t an isolated incident; the virus began to reappear in herds across multiple states. Studies suggest numerous transmissions from cows to humans have occurred, often without apparent symptoms.
The primary fear is that the virus will adapt to transmit effectively between humans, a necessary step for a new pandemic to emerge.
As of now, the Centers for Disease Control and Prevention (CDC) has reported 71 human cases and two deaths in the US since 2024, with no evidence of sustained community transmission. However, specific vaccines are being developed, as current formulations may not offer sufficient protection against this strain.
Mpox: Two Variants in Global Circulation
For decades, mpox (formerly known as monkeypox) was a rare disease largely confined to certain regions of Africa. This changed in 2022, when a global outbreak of the IIb clade spread to over one hundred countries. Transmission through close physical contact, often during sexual activity, marked a turning point, transforming the virus from a localized phenomenon into one circulating recurrently worldwide.
Concurrently, countries in Central Africa have reported increases in infections from the clade I, considered more severe. The United States has also recently reported cases of clade Ib in individuals with no history of travel to Africa. While a vaccine exists, there is currently no specific treatment, and experts warn that the virus’s evolution in 2026 could present new health challenges.
Other Viral Threats in 2026
Beyond these three primary concerns, other viruses are also beginning to generate concern. Chikungunya, for example, resulted in over 445,000 suspected and confirmed cases in 2025, with at least 155 reported deaths as of September.
The Nipah virus is also under renewed surveillance following a recent outbreak in West Bengal, although experts emphasize that it currently does not appear capable of triggering a pandemic.
diseases like measles are re-emerging in various countries due to declining vaccination rates, potentially jeopardizing elimination status in places like the United States. Some experts also caution that HIV could experience a resurgence if international health cooperation programs continue to face budget cuts.
These developments serve as a reminder that the sense that the COVID-19 pandemic was an exceptional and fully overcome event may be premature. The key takeaway is that in a world where ecosystems are changing and human mobility facilitates pathogen circulation, constant vigilance and preparedness remain crucial tools for preventing local outbreaks from escalating into global crises.